Advancing Care of Heart Failure and Chronic Kidney Disease with Non-Steroidal MRAs
Uncontrolled hypertension can lead to severe complications such as chronic kidney disease (CKD), heart failure, and stroke, including lethal outcomes. In 2019, high systolic blood pressure was the leading risk factor for global attributable deaths in females and the second leading risk factor in males, accounting for 10.85 million deaths.
Treating hypertension and associated conditions effectively is therefore highly important. This webcast was recorded live at our Sciarc symposium at the World Hypertension Congress 2025 and updates you on current study data and innovative approaches to tackling heart failure and chronic kidney disease as common consequences of hypertension.
8 March 2025
Chennai, India
Bridging gaps for treatment of heart failure and chronic kidney disease – Key characteristics of non-steroidal MRAs
Speaker: Prof. Roland Schmieder
Erlangen, Germany
Lectures
Prof. Roland Schmieder
Erlangen, Germany
Bridging gaps for treatment of heart failure and chronic kidney disease – Key characteristics of non-steroidal MRAs
Current LectureProf. Per-Henrik Groop
Helsinki, Finland
Pioneering outcomes for improved heart failure and CKD: Treatment with finerenone
Watch LectureProf. Michael Böhm
Homburg/Saar, Germany
Non-steroidal MRAs in heart failure management: Practical considerations and future directions
Watch LectureThese lectures are available as an EACCME-certified webcast from May 22, 2025 to May 22, 2027.